生物标志物 生物标志物
Dishaa Sinha1, Kushagra Soni2, Ishan Durve3
1University of Oxford, Oxford, Oxfordshire, United Kingdom.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 26, 2025
概括
使用心血管和语音数据预测阿尔茨海默病 (AD) ATN 病理表明有希望. 结合这些非侵入性标记物显著提高了诊断准确度,为早期检测提供了可扩展的方法.
科学领域:
- 神经科学是一个神经科学.
- 生物标志物发现发现
- 计算生物学 计算生物学
背景情况:
- 阿尔茨海默氏病 (AD) 构成了越来越大的医疗保健挑战,需要早期诊断才能进行有效的干预.
- 传统的AD诊断 (神经成像,侵入性生物标志物) 是昂贵的,并且无法用于例行监测.
- 非侵入性,负担得起的生物标志物对于早期阿尔茨海默病检测至关重要,与ATN (粉样蛋白,陶蛋白,神经退行) 框架保持一致.
研究的目的:
- 调查语音特征和心血管因素对预测阿尔茨海默病 (AD) ATN病理学的潜力.
- 使用集成的非侵入性数据开发和比较用于早期AD检测的机器学习模型.
- 建立一个可扩展和可访问的AD诊断方法.
主要方法:
- 来自使用Bio-Hermes平台的1,011名参与者的综合数据.
- 用生物标志物值将参与者分为ATN组和临床类别 (认知健康,MCI,AD).
- 开发和评估了四种XGBoost模型:基线,心血管,语音和组合,结合了人口统计,生活方式,心血管和语音特征.
主要成果:
- 基线模型实现了0.9103的ROC-AUC和0.7097.7的精度.
- 心血管和语音模型的性能有所改善,ROC-AUC分别为0.9254和0.9416.
- 整合所有特征的组合模型产生了最高的性能,ROC-AUC为0.9539和准确率为0.8260.
结论:
- 整合心血管和语音特征显著提高了阿尔茨海默病中ATN病理的预测.
- 这些非侵入性标志物表明了可扩展,具有成本效益的早期AD检测的潜力.
- 这些发现支持开发新型工具,以减少对AD的侵入性诊断方法的依赖.
相关概念视频
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516